Legend Biotech Q2 EPS $(0.05) Beats $(0.38) Estimate, Sales $186.52M Beat $126.59M Estimate
Author: Benzinga Newsdesk | August 09, 2024 07:04am
Legend Biotech (NASDAQ:
LEGN) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.38) by 86.84 percent. This is a 91.23 percent increase over losses of $(0.57) per share from the same period last year. The company reported quarterly sales of $186.52 million which beat the analyst consensus estimate of $126.59 million by 47.34 percent. This is a 154.36 percent increase over sales of $73.33 million the same period last year.
Posted In: LEGN